BCAS1 and glioblastoma: To explore why BCAS1-SV1 promotes the carcinogenesis potential of GBM, we used yeast two-hybrid technology to find possible direct targets of BCAS1-SV1 and identified β-arrestin 2 as a candidate specific binding target.